Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 4684

1.

Activation of peroxisome proliferator-activated receptor gamma/small heterodimer partner pathway prevents high fat diet-induced obesity and hepatic steatosis in Sprague-Dawley rats fed soybean meal.

Matsumoto Y, Ishimi Y, Suzuki T, Kobayashi KI, Inoue J, Yamamoto Y.

J Nutr Biochem. 2019 Oct 15;75:108250. doi: 10.1016/j.jnutbio.2019.108250. [Epub ahead of print]

PMID:
31707284
2.

In Vitro Study of the Anti-cancer Effect of Alternate-day 5-Fluorouracil in Head and Neck Cancer Cells.

Moro Y, Kogashiwa Y, Sakurai H, Takahashi R, Kimura T, Hirasaki M, Matsumoto Y, Sugasawa M, Kohno N.

Anticancer Res. 2019 Nov;39(11):6041-6047. doi: 10.21873/anticanres.13810.

PMID:
31704830
3.

Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.

Kishikawa T, Maeda Y, Nii T, Motooka D, Matsumoto Y, Matsushita M, Matsuoka H, Yoshimura M, Kawada S, Teshigawara S, Oguro E, Okita Y, Kawamoto K, Higa S, Hirano T, Narazaki M, Ogata A, Saeki Y, Nakamura S, Inohara H, Kumanogoh A, Takeda K, Okada Y.

Ann Rheum Dis. 2019 Nov 7. pii: annrheumdis-2019-215743. doi: 10.1136/annrheumdis-2019-215743. [Epub ahead of print]

4.

Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease.

Suda A, Takahashi J, Hao K, Kikuchi Y, Shindo T, Ikeda S, Sato K, Sugisawa J, Matsumoto Y, Miyata S, Sakata Y, Shimokawa H.

J Am Coll Cardiol. 2019 Nov 12;74(19):2350-2360. doi: 10.1016/j.jacc.2019.08.1056.

5.

Corrosive injury of upper gastrointestinal tract by calcium oxide.

Yoshida M, Matsumoto Y, Suzuki T, Nishimura S, Kato T, Shimura K, Kaneko H, Taniwaki M.

Indian J Gastroenterol. 2019 Nov 6. doi: 10.1007/s12664-019-00992-1. [Epub ahead of print] No abstract available.

PMID:
31691899
6.

Influence of dioxin-related compounds on physical function in Yusho incident victims.

Fukushi JI, Tsushima H, Matsumoto Y, Mitoma C, Furue M, Miyahara H, Nakashima Y.

Heliyon. 2019 Oct 23;5(10):e02702. doi: 10.1016/j.heliyon.2019.e02702. eCollection 2019 Oct.

7.

Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma.

Matsumoto Y, Chinen Y, Shimura Y, Nagoshi H, Sasaki N, Muramatsu A, Kuriyama K, Ohshiro M, Hirakawa Y, Iwai T, Uchiyama H, Taki T, Horiike S, Kuroda J, Taniwaki M.

Int J Hematol. 2019 Nov 4. doi: 10.1007/s12185-019-02766-z. [Epub ahead of print]

PMID:
31686349
8.

Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.

Suzuki M, Cao K, Kato S, Komizu Y, Mizutani N, Tanaka K, Arima C, Tai MC, Yanagisawa K, Togawa N, Shiraishi T, Usami N, Taniguchi T, Fukui T, Yokoi K, Wakahara K, Hasegawa Y, Mizutani Y, Igarashi Y, Inokuchi JI, Iwaki S, Fujii S, Satou A, Matsumoto Y, Ueoka R, Tamiya-Koizumi K, Murate T, Nakamura M, Kyogashima M, Takahashi T.

J Clin Invest. 2019 Nov 1;129(11):5050. doi: 10.1172/JCI133806. No abstract available.

9.

Frequency and predictors of perioperative psychiatric symptom worsening among patients with psychiatric disorders.

Matsumoto Y, Ayani N, Narumoto J.

Compr Psychiatry. 2019 Oct 16;95:152138. doi: 10.1016/j.comppsych.2019.152138. [Epub ahead of print]

10.

Prospective observational study on the safety of an original fiducial marker insertion for radiotherapy in gynecological cancer by a simple method.

Sekii S, Tsujino K, Kubota H, Yamaguchi S, Kosaka K, Miyazaki S, Sulaiman NS, Matsumoto Y, Ota Y, Soejima T, Sasaki R.

J Radiat Res. 2019 Oct 28. pii: rrz070. doi: 10.1093/jrr/rrz070. [Epub ahead of print]

PMID:
31665384
11.

Reprogramming and differentiation-dependent transcriptional alteration of DNA damage response and apoptosis genes in human induced pluripotent stem cells.

Shimada M, Tsukada K, Kagawa N, Matsumoto Y.

J Radiat Res. 2019 Oct 28. pii: rrz057. doi: 10.1093/jrr/rrz057. [Epub ahead of print]

PMID:
31665364
12.

Structural Determination of Lysosphingomyelin-509 and Discovery of Novel Class Lipids from Patients with Niemann-Pick Disease Type C.

Maekawa M, Jinnoh I, Matsumoto Y, Narita A, Mashima R, Takahashi H, Iwahori A, Saigusa D, Fujii K, Abe A, Higaki K, Yamauchi S, Ozeki Y, Shimoda K, Tomioka Y, Okuyama T, Eto Y, Ohno K, T Clayton P, Yamaguchi H, Mano N.

Int J Mol Sci. 2019 Oct 10;20(20). pii: E5018. doi: 10.3390/ijms20205018.

13.

Correlation and Characteristics of Intravoxel Incoherent Motion and Arterial Spin Labeling Techniques Versus Multiple Parameters Obtained on Dynamic Susceptibility Contrast Perfusion MRI for Brain Tumors.

Dolgorsuren EA, Harada M, Kanazawa Y, Abe T, Otomo M, Matsumoto Y, Mizobuchi Y, Nakajima K.

J Med Invest. 2019;66(3.4):308-313. doi: 10.2152/jmi.66.308.

14.

Epithelial EP4 plays an essential role in maintaining homeostasis in colon.

Matsumoto Y, Nakanishi Y, Yoshioka T, Yamaga Y, Masuda T, Fukunaga Y, Sono M, Yoshikawa T, Nagao M, Araki O, Ogawa S, Goto N, Hiramatsu Y, Breyer RM, Fukuda A, Seno H.

Sci Rep. 2019 Oct 23;9(1):15244. doi: 10.1038/s41598-019-51639-2.

15.

Method of determining pyrrole-imidazole polyamide in rat plasma using ultra-fast liquid chromatography-ultraviolet spectrometry.

Miyamoto A, Yagishita K, Aoyama T, Abe M, Fukuda N, Matsumoto Y.

Biol Pharm Bull. 2019 Oct 24. doi: 10.1248/bpb.b19-00644. [Epub ahead of print]

16.

Total Synthesis and Structure-Activity Relationship Study of Vineomycin A1.

Matsumoto Y, Kuriki H, Kitamura T, Takahashi D, Toshima K.

J Org Chem. 2019 Nov 6. doi: 10.1021/acs.joc.9b02304. [Epub ahead of print]

PMID:
31642324
17.

A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes.

Ishikawa M, Kasamatsu T, Tsuda H, Fukunaga M, Sakamoto A, Kaku T, Kato T, Takahashi K, Ariyoshi K, Suzuki K, Arimoto T, Matsumoto Y, Nakai H, Inoue T, Yokoyama M, Kawabata T, Kodama S, Miyamoto T, Takano M, Yaegashi N.

Gynecol Oncol. 2019 Oct 18. pii: S0090-8258(19)31540-9. doi: 10.1016/j.ygyno.2019.09.018. [Epub ahead of print]

PMID:
31635755
18.

[Prognostic Value of Preoperative Serum C-Reactive Protein Level in Gastric Cancer].

Matsumoto Y, Kosuga T, Konishi T, Kudou M, Shoda K, Arita T, Konishi H, Morimura R, Murayama Y, Shiozaki A, Kuriu Y, Ikoma H, Kubota T, Nakanishi M, Okamoto K, Fujiwara H, Otsuji E.

Gan To Kagaku Ryoho. 2019 Oct;46(10):1623-1625. Japanese.

PMID:
31631155
19.

How successful are we in relieving terminal dyspnea in cancer patients? A real-world multicenter prospective observational study.

Mori M, Morita T, Matsuda Y, Yamada H, Kaneishi K, Matsumoto Y, Matsuo N, Odagiri T, Aruga E, Watanabe H, Tatara R, Sakurai H, Kimura A, Katayama H, Suga A, Nishi T, Shirado AN, Watanabe T, Kuchiba A, Yamaguchi T, Iwase S.

Support Care Cancer. 2019 Oct 19. doi: 10.1007/s00520-019-05081-9. [Epub ahead of print]

PMID:
31630256
20.

Variable dependency on BAFF in IgG antibody production during Leishmania infection.

Azuma N, Omachi S, Hanazawa W, Morimoto A, Sanjoba C, Matsumoto Y, Fujii W, Goto Y.

Parasitol Int. 2020 Feb;74:101997. doi: 10.1016/j.parint.2019.101997. Epub 2019 Oct 15.

PMID:
31626986
21.

Transcriptome Characterization of Reverse Development in Turritopsis dohrnii (Hydrozoa, Cnidaria).

Matsumoto Y, Piraino S, Miglietta MP.

G3 (Bethesda). 2019 Oct 16. pii: g3.400487.2019. doi: 10.1534/g3.119.400487. [Epub ahead of print]

22.

Suppressive effects of whey protein hydrolysate on sucrose-induced hyperglycemia in silkworms.

Matsumoto Y, Takahashi M, Umehara M, Asano M, Maruki-Uchida H, Morita M, Sekimizu K.

Drug Discov Ther. 2019 Oct 14. doi: 10.5582/ddt.2019.01069. [Epub ahead of print]

23.

Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia.

Kikuchi Y, Takahashi J, Hao K, Sato K, Sugisawa J, Tsuchiya S, Suda A, Shindo T, Ikeda S, Shiroto T, Matsumoto Y, Miyata S, Sakata Y, Shimokawa H.

Int J Cardiol. 2019 Oct 8. pii: S0167-5273(19)33201-2. doi: 10.1016/j.ijcard.2019.09.057. [Epub ahead of print]

PMID:
31611086
24.

Contrast Material Injection Protocol With the Dose Determined According to Lean Body Weight at Hepatic Dynamic Computed Tomography: Comparison Among Patients With Different Body Mass Indices.

Matsumoto Y, Masuda T, Sato T, Arataki K, Nakamura Y, Tatsugami F, Awai K.

J Comput Assist Tomogr. 2019 Sep/Oct;43(5):736-740. doi: 10.1097/RCT.0000000000000909.

PMID:
31609293
25.

Piezo-assisted ICSI improves fertilization and blastocyst development rates compared with conventional ICSI in women aged more than 35 years.

Furuhashi K, Saeki Y, Enatsu N, Iwasaki T, Ito K, Mizusawa Y, Matsumoto Y, Kokeguchi S, Shiotani M.

Reprod Med Biol. 2019 Aug 24;18(4):357-361. doi: 10.1002/rmb2.12290. eCollection 2019 Oct.

26.

MitraClip Therapy for Healed Infective Endocarditis - How Long Should We Wait After Active Infection?

Kato Y, Amaki M, Kanzaki H, Kataoka Y, Okada A, Miyamoto K, Hamatani Y, Amano M, Takahama H, Hasegawa T, Matsumoto Y, Fujita T, Kobayashi J, Ishibashi-Ueda H, Yasuda S, Izumi C.

Circ J. 2019 Oct 10. doi: 10.1253/circj.CJ-19-0523. [Epub ahead of print] No abstract available.

27.

Aneurysm-type Plexiform Lesions Form in Supernumerary Arteries in Pulmonary Arterial Hypertension: Potential Therapeutic Implications.

Oshima K, Crockett ES, Joshi SR, McLendon JM, Matsumoto Y, McMurtry IF, Abe K, Oka M.

Am J Physiol Lung Cell Mol Physiol. 2019 Oct 2. doi: 10.1152/ajplung.00121.2019. [Epub ahead of print]

PMID:
31577161
28.

Pulsed laser deposition with rapid beam deflection by a galvanometer mirror scanner.

Maruyama S, Sannodo N, Harada R, Anada Y, Takahashi R, Lippmaa M, Matsumoto Y.

Rev Sci Instrum. 2019 Sep;90(9):093901. doi: 10.1063/1.5104291.

PMID:
31575232
29.

A Multicenter Cohort Study to Explore Differentiating Factors between Tumor Fever and Infection among Advanced Cancer Patients.

Odagiri T, Morita T, Sakurai H, Yamada H, Matsuo N, Matsumoto Y, Matsuda Y, Yoshioka A, Watanabe H, Shimoyama S, Kohara H.

J Palliat Med. 2019 Nov;22(11):1331-1336. doi: 10.1089/jpm.2018.0594. Epub 2019 Sep 30.

PMID:
31566480
30.

In Vitro Reconstruction of Xenopus Oocyte Ovulation.

Tokmakov AA, Matsumoto Y, Isobe T, Sato KI.

Int J Mol Sci. 2019 Sep 26;20(19). pii: E4766. doi: 10.3390/ijms20194766.

31.

Transanal TME: new standard or fad?

Hasegawa S, Yoshida Y, Morimoto M, Kojima D, Komono A, Aisu N, Taketomi H, Nagano H, Matsumoto Y, Munechika T, Kajitani R.

J Anus Rectum Colon. 2019 Jan 29;3(1):1-9. doi: 10.23922/jarc.2018-030. eCollection 2019. Review.

32.

Robotic minimally invasive direct coronary artery bypass for Kawasaki disease.

Matsumoto Y, Fukushima S, Shimahara Y, Kawamoto N, Tadokoro N, Kitamura S, Kobayashi J, Fujita T.

Gen Thorac Cardiovasc Surg. 2019 Sep 25. doi: 10.1007/s11748-019-01215-2. [Epub ahead of print]

PMID:
31555956
33.

A case of AL amyloidosis associated with follicular lymphoma with plasmacytic differentiation.

Matsumoto Y, Masuda T, Nishimura A, Horie H, Harada K, Yoshida M, Shimura K, Kaneko H, Taniwaki M.

Int J Hematol. 2019 Sep 21. doi: 10.1007/s12185-019-02734-7. [Epub ahead of print]

PMID:
31542852
34.

Acute Effects of Transdermal Administration of Jojoba Oil on Lipid Metabolism in Mice.

Matsumoto Y, Ma S, Tominaga T, Yokoyama K, Kitatani K, Horikawa K, Suzuki K.

Medicina (Kaunas). 2019 Sep 15;55(9). pii: E594. doi: 10.3390/medicina55090594.

35.

Induction of signal transduction pathways related to the pathogenicity of Cryptococcus neoformans in the host environment.

Matsumoto Y, Azami S, Shiga H, Nagamachi T, Moriyama H, Yamashita Y, Yoshikawa A, Sugita T.

Drug Discov Ther. 2019;13(4):177-182. doi: 10.5582/ddt.2019.01047.

36.

Superconductivity at 4.8 K and Violation of Pauli Limit in La2IRu2 Comprising Ru Honeycomb Layer.

Ishikawa H, Wedig U, Nuss J, Kremer RK, Dinnebier R, Blankenhorn M, Pakdaman M, Matsumoto Y, Takayama T, Kitagawa K, Takagi H.

Inorg Chem. 2019 Oct 7;58(19):12888-12894. doi: 10.1021/acs.inorgchem.9b01825. Epub 2019 Sep 13.

PMID:
31518128
37.

Enhanced structural disorder at a nanocrystalline ice surface.

Otsuki Y, Watanabe K, Sugimoto T, Matsumoto Y.

Phys Chem Chem Phys. 2019 Sep 18;21(36):20442-20453. doi: 10.1039/c8cp07269h.

PMID:
31502600
38.

[Ischemic Priapism Associated with Essential Thrombocythemia : A Case Report].

Matsumoto Y, Amano T, Shimojima Y, Imao T, Kato H.

Hinyokika Kiyo. 2019 Jul;65(7):315-317. doi: 10.14989/ActaUrolJap_65_7_315. Japanese.

PMID:
31501399
39.

[A Case of Ureteroarterial Fistula Successfully Treated with Endovascular Stent Graft].

Kuramoto T, Muraoka S, Nishikawa T, Matsumoto Y, Uokawa K.

Hinyokika Kiyo. 2019 Jul;65(7):299-303. doi: 10.14989/ActaUrolJap_65_7_299. Japanese.

PMID:
31501396
40.

Left ventricular assist device implantation in an adult male with Danon disease.

Kuroda K, Seguchi O, Matama H, Kimura Y, Iwasaki K, Toda K, Kikuchi N, Kumai Y, Nakajima S, Matsumoto Y, Watanabe T, Yanase M, Fukushima S, Tomoyuki F, Kobayashi J, Fukushima N.

J Cardiol Cases. 2019 Jul 8;20(3):106-109. doi: 10.1016/j.jccase.2019.06.002. eCollection 2019 Sep.

41.

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma.

Makii C, Ikeda Y, Oda K, Uehara Y, Nishijima A, Koso T, Kawata Y, Kashiyama T, Miyasaka A, Sone K, Tanikawa M, Tsuruga T, Mori-Uchino M, Nagasaka K, Matsumoto Y, Wada-Hiraike O, Kawana K, Hasegawa K, Fujiwara K, Aburatani H, Osuga Y, Fujii T.

Gynecol Oncol. 2019 Nov;155(2):331-339. doi: 10.1016/j.ygyno.2019.08.028. Epub 2019 Sep 5.

PMID:
31493899
42.

Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.

Tanaka K, Mizusawa J, Naka N, Kawai A, Katagiri H, Hiruma T, Matsumoto Y, Tsuchiya H, Nakayama R, Hatano H, Emori M, Watanuki M, Yoshida Y, Okamoto T, Abe S, Asanuma K, Yokoyama R, Hiraga H, Yonemoto T, Morii T, Ae K, Nagano A, Yoshikawa H, Fukuda H, Ozaki T, Iwamoto Y.

BMC Cancer. 2019 Sep 6;19(1):890. doi: 10.1186/s12885-019-6114-2.

43.

Early postoperative heparinization reduce hemolysis in patients with HeartMate II devices.

Matsumoto Y, Fukushima S, Shimahara Y, Kawamoto N, Tadokoro N, Kuroda K, Nakajima S, Watanabe T, Seguchi O, Yanase M, Fukushima N, Shimizu H, Kobayashi J, Fujita T.

J Artif Organs. 2019 Sep 4. doi: 10.1007/s10047-019-01129-z. [Epub ahead of print]

PMID:
31482437
44.

Treatments and outcomes of older patients with esophageal cancer: Comparison with younger patients.

Matsumoto Y, Kimura K, Zhou Q, Sasaki K, Saiki T, Moriyama M, Saijo Y.

Mol Clin Oncol. 2019 Oct;11(4):383-389. doi: 10.3892/mco.2019.1909. Epub 2019 Aug 9.

45.

Maturational Characterization of Mouse Cortical Neurons Three-Dimensionally Cultured in Functional Polymer FP001-Containing Medium.

Nakamichi N, Matsumoto Y, Kawanishi T, Ishimoto T, Masuo Y, Horikawa M, Kato Y.

Biol Pharm Bull. 2019;42(9):1545-1553. doi: 10.1248/bpb.b19-00307.

46.

A Case Report of Umbilical Vein Varix with Thrombosis: Prenatal Ultrasonographic Diagnosis and Management.

Matsumoto Y, Yanai A, Kamei S, Yamaguchi A, Nakamine H, Fujita K.

Case Rep Obstet Gynecol. 2019 Aug 6;2019:7154560. doi: 10.1155/2019/7154560. eCollection 2019.

47.

Attenuation Effects of Alpha-Pinene Inhalation on Mice with Dizocilpine-Induced Psychiatric-Like Behaviour.

Ueno H, Shimada A, Suemitsu S, Murakami S, Kitamura N, Wani K, Matsumoto Y, Okamoto M, Ishihara T.

Evid Based Complement Alternat Med. 2019 Jul 30;2019:2745453. doi: 10.1155/2019/2745453. eCollection 2019.

48.

Predictive factors of mortality of patients with fragility hip fractures at 1 year after discharge: A multicenter, retrospective study in the northern Kyushu district of Japan.

Kimura A, Matsumoto Y, Wakata Y, Oyamada A, Ohishi M, Fujiwara T, Ikuta K, Tsuchiya K, Tayama N, Tomari S, Miyahara H, Mae T, Hara T, Saito T, Arizono T, Kaji K, Mawatari T, Fujiwara M, Sakimura R, Shin K, Ninomiya K, Nakaie K, Antoku Y, Tokunaga S, Nakashima N, Iwamoto Y, Nakashima Y.

J Orthop Surg (Hong Kong). 2019 Sep-Dec;27(3):2309499019866965. doi: 10.1177/2309499019866965.

PMID:
31466509
49.

Efficacy and safety of crizotinib in patients with ROS1 rearranged non-small cell lung cancer: a retrospective analysis.

Masuda K, Fujiwara Y, Shinno Y, Mizuno T, Sato J, Morita R, Matsumoto Y, Murakami S, Goto Y, Kanda S, Horinouchi H, Yamamoto N, Ohe Y.

J Thorac Dis. 2019 Jul;11(7):2965-2972. doi: 10.21037/jtd.2019.07.44.

50.

Role of Gallium-SPECT-CT in the Management of Patients With Ventricular Assist Device-Specific Percutaneous Driveline Infection.

Kimura Y, Seguchi O, Mochizuki H, Iwasaki K, Toda K, Kumai Y, Kuroda K, Nakajima S, Tateishi E, Watanabe T, Matsumoto Y, Fukushima S, Kiso K, Yanase M, Fujita T, Kobayashi J, Fukushima N.

J Card Fail. 2019 Oct;25(10):795-802. doi: 10.1016/j.cardfail.2019.08.009. Epub 2019 Aug 24.

PMID:
31454687

Supplemental Content

Loading ...
Support Center